<?xml version="1.0" encoding="UTF-8"?>
<p>After the first week, the reduction reached 20% for PCS at the dose of 25 and 25% for the dose of 50. After that, diabetic condition and hyperglycemia were successfully controlled indicated by a significant reduction (
 <italic>p</italic> &lt; 0.001) (Day 14: 35,58,44%; Day 21: 44,61,63%; Day 28: 57,65,73% for doses 25, 50 and, glibenclamide, respectively) compared to the negative control.
</p>
